Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can you prick your finger in space? scientists find out

NCT ID NCT06431984

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether healthy volunteers with minimal training could collect their own blood using a finger prick during brief periods of weightlessness on parabolic flights. The goal was to see if the blood samples were good enough to measure caffeine levels. Thirty participants took part, and the study focused on how well the self-sampling worked in microgravity compared to on the ground.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this method could enable simple blood sampling in space, helping researchers understand how drugs work in astronauts.
What could go wrong
This is a small, early feasibility study with only 30 participants. It tests a method, not a treatment, and may not work in real spaceflight conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Mar 2023

Finished

Apr 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be affiliated to a social security scheme or benefit from such a scheme. * Have obtained a medical certificate stating that they are fit for parabolic flights. * Be aged between 18 and 70 * Be in good health: no chronic treatment that could interact with the metabolism of caffeine, no progressive disease * Must not have any contraindications to taking caffeine (30 to 100 mg). Volunteers will also be asked not to consume caffeine (coffee, chocolate, energy drinks, tea, cola, etc.) in the 24 hours preceding the experiment. Exclusion Criteria: * Be the subject of a legal protection measure (safeguard of justice, curatorship or guardianship) * suffer from haematophobia (irrational fear of blood) * Have a current infectious disease, particularly viral * Have an active chronic illness * Have a high usual intake of caffeine (\>4 espressos, \>4 cups of tea, \>100g dark chocolate per day) * Total intolerance to all forms of caffeine * Smoke more than 20 cigarettes a day * Have weaned themselves off smoking for less than a month * Have a history of severe Raynaud's phenomenon * Have a history of naupathy * Suffering from naupathy during a flight

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Drug mechanism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AIRBUS A 310 - Zero-G

    Mérignac, 33700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.